Cargando…
Inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by gaseous ozone treatment
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Healthcare Infection Society. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547371/ https://www.ncbi.nlm.nih.gov/pubmed/33049366 http://dx.doi.org/10.1016/j.jhin.2020.10.004 |
_version_ | 1783592406282665984 |
---|---|
author | Yano, H. Nakano, R. Suzuki, Y. Nakano, A. Kasahara, K. Hosoi, H. |
author_facet | Yano, H. Nakano, R. Suzuki, Y. Nakano, A. Kasahara, K. Hosoi, H. |
author_sort | Yano, H. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7547371 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Healthcare Infection Society. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75473712020-10-13 Inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by gaseous ozone treatment Yano, H. Nakano, R. Suzuki, Y. Nakano, A. Kasahara, K. Hosoi, H. J Hosp Infect Letter to the Editor The Healthcare Infection Society. Published by Elsevier Ltd. 2020-12 2020-10-10 /pmc/articles/PMC7547371/ /pubmed/33049366 http://dx.doi.org/10.1016/j.jhin.2020.10.004 Text en © 2020 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Yano, H. Nakano, R. Suzuki, Y. Nakano, A. Kasahara, K. Hosoi, H. Inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by gaseous ozone treatment |
title | Inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by gaseous ozone treatment |
title_full | Inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by gaseous ozone treatment |
title_fullStr | Inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by gaseous ozone treatment |
title_full_unstemmed | Inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by gaseous ozone treatment |
title_short | Inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by gaseous ozone treatment |
title_sort | inactivation of severe acute respiratory syndrome coronavirus 2 (sars-cov-2) by gaseous ozone treatment |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547371/ https://www.ncbi.nlm.nih.gov/pubmed/33049366 http://dx.doi.org/10.1016/j.jhin.2020.10.004 |
work_keys_str_mv | AT yanoh inactivationofsevereacuterespiratorysyndromecoronavirus2sarscov2bygaseousozonetreatment AT nakanor inactivationofsevereacuterespiratorysyndromecoronavirus2sarscov2bygaseousozonetreatment AT suzukiy inactivationofsevereacuterespiratorysyndromecoronavirus2sarscov2bygaseousozonetreatment AT nakanoa inactivationofsevereacuterespiratorysyndromecoronavirus2sarscov2bygaseousozonetreatment AT kasaharak inactivationofsevereacuterespiratorysyndromecoronavirus2sarscov2bygaseousozonetreatment AT hosoih inactivationofsevereacuterespiratorysyndromecoronavirus2sarscov2bygaseousozonetreatment |